{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:16:29Z","timestamp":1784747789594,"version":"3.55.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12035-025-05112-z","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T16:08:39Z","timestamp":1749312519000},"page":"15132-15148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Central Role of Actin in Creutzfeldt-Jakob Disease: Unlocking Therapeutic Pathways"],"prefix":"10.1007","volume":"62","author":[{"given":"Liliana","family":"Bastar-Juarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena","family":"Castillo-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Margarit-Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4159-4282","authenticated-orcid":false,"given":"Paola","family":"Coca-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,7]]},"reference":[{"issue":"1","key":"5112_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41580-018-0067-1","volume":"20","author":"M Dogterom","year":"2018","unstructured":"Dogterom M, Koenderink GH (2018) Actin\u2013microtubule crosstalk in cell biology. Nat Rev Mol Cell Biol [Internet]. 20(1):38\u201354. https:\/\/doi.org\/10.1038\/s41580-018-0067-1","journal-title":"Nat Rev Mol Cell Biol [Internet]."},{"key":"5112_CR2","doi-asserted-by":"publisher","unstructured":"Konietzny A, B\u00e4r J, Mikhaylova M (2017) Dendritic actin cytoskeleton: structure, functions, and regulations. Front Cell Neurosci [Internet]. 11. https:\/\/doi.org\/10.3389\/fncel.2017.00147","DOI":"10.3389\/fncel.2017.00147"},{"key":"5112_CR3","unstructured":"Sitammagari KK, Masood W (2024) Creutzfeldt Jakob Disease [Internet]. StatPearls - NCBI Bookshelf. Available at https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507860\/"},{"issue":"2","key":"5112_CR4","doi-asserted-by":"publisher","first-page":"e1009359","DOI":"10.1371\/journal.pgen.1009359","volume":"17","author":"S Sarkar","year":"2021","unstructured":"Sarkar S, Olsen AL, Sygnecka K, Lohr KM, Feany MB (2021) \u03b1-synuclein impairs autophagosome maturation through abnormal actin stabilization. PLoS Genetics [Internet]. 17(2):e1009359. https:\/\/doi.org\/10.1371\/journal.pgen.1009359","journal-title":"PLoS Genetics [Internet]."},{"key":"5112_CR5","doi-asserted-by":"publisher","unstructured":"Sarkar S, Bardai F, Olsen AL, Lohr KM, Zhang YY, Feany MB (2021) Oligomerization of Lrrk controls actin severing and \u03b1-synuclein neurotoxicity in vivo. Molecular Neurodegeneration [Internet]. 16(1). Available from: https:\/\/doi.org\/10.1186\/s13024-021-00454-3","DOI":"10.1186\/s13024-021-00454-3"},{"key":"5112_CR6","doi-asserted-by":"publisher","unstructured":"Freischmidt A, Sch\u00f6pflin M, Feiler MS, Fleck AK, Ludolph AC, Weishaupt JH (2015) Profilin 1 with the amyotrophic lateral sclerosis associated mutation T109M displays unaltered actin-binding and does not affect the actin cytoskeleton. BMC Neuroscience [Internet]. 16(1). Available from: https:\/\/doi.org\/10.1186\/s12868-015-0214-y","DOI":"10.1186\/s12868-015-0214-y"},{"issue":"6","key":"5112_CR7","doi-asserted-by":"publisher","first-page":"1708.e1","DOI":"10.1016\/j.neurobiolaging.2012.10.009","volume":"34","author":"C Ingre","year":"2012","unstructured":"Ingre C, Landers JE, Rizik N, Volk AE, Akimoto C, Birve A et al (2012) A novel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis\/frontotemporal dementia cohorts. Neurobiol Aging [Internet]. 34(6):1708.e1-1708.e6. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.10.009","journal-title":"Neurobiol Aging [Internet]."},{"issue":"24","key":"5112_CR8","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.1523\/jneurosci.0543-14.2014","volume":"34","author":"MD Figley","year":"2014","unstructured":"Figley MD, Bieri G, Kolaitis RM, Taylor JP, Gitler AD (2014) Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics. J Neurosci [Internet]. 34(24):8083\u201397. https:\/\/doi.org\/10.1523\/jneurosci.0543-14.2014","journal-title":"J Neurosci [Internet]."},{"issue":"609","key":"5112_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neulet.2015.09.034","volume":"24","author":"M Brettle","year":"2015","unstructured":"Brettle M, Suchowerska AK, Chua SW, Ittner LM, Fath T (2015) Amyotrophic lateral sclerosis-associated mutant profilin 1 increases dendritic arborisation and spine formation in primary hippocampal neurons. Neurosci Lett 24(609):223\u20138. https:\/\/doi.org\/10.1016\/j.neulet.2015.09.034","journal-title":"Neurosci Lett"},{"key":"5112_CR10","doi-asserted-by":"crossref","unstructured":"Henry R, Murphy FA (2017) Etymologia: Creutzfeldt-Jakob disease. Emerging Infectious Diseases [Internet]. 23(6):956. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5443459\/","DOI":"10.3201\/eid2306.ET2306"},{"key":"5112_CR11","unstructured":"Prion diseases [Internet]. Johns Hopkins Medicine. 2024. Available at: https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/prion-diseases"},{"key":"5112_CR12","unstructured":"Classification of sporadic Creutzfeldt\u2010Jakob disease based on molecular and phenotypic analysis of 300 subjects | Semantic Scholar [Internet]. [citado 22 de diciembre de 2024]. Disponible en: https:\/\/www.semanticscholar.org\/paper\/Classification-of-sporadic-Creutzfeldt%E2%80%90Jakob-based-Parchi-Giese\/30e86a6f6bb705a0e58b870f652617052ba254ad"},{"issue":"1","key":"5112_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","volume":"66","author":"P Gambetti","year":"2003","unstructured":"Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterisation. British Med Bull 66(1):213\u201339","journal-title":"British Med Bull"},{"key":"#cr-split#-5112_CR14.1","doi-asserted-by":"crossref","unstructured":"Budka H, Head MW, Ironside JW, Gambetti P, Parchi P, Tagliavini F (2011) Sporadic Creutzfeldt-Jakob disease. En: Neurodegeneration: the molecular pathology of dementia and movement disorders [Internet]. John Wiley & Sons, Ltd","DOI":"10.1002\/9781444341256.ch32"},{"key":"#cr-split#-5112_CR14.2","unstructured":"[citado 22 de diciembre de 2024]. p. 322-35. Disponible en: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/9781444341256.ch32"},{"issue":"5","key":"5112_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jamda.2021.08.010","volume":"23","author":"Y Sun","year":"2022","unstructured":"Sun Y, Fan LY, Huang CT, Liu CC, Chen TF, Lu CJ et al (2022) Prognostic features of sporadic Creutzfeldt-Jakob disease: an analysis of Taiwan\u2019s nationwide surveillance. J Am Med Directors Association. 23(5):845\u201351","journal-title":"J Am Med Directors Association."},{"issue":"1","key":"5112_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1034\/j.1600-0463.2002.100111.x","volume":"110","author":"I Zerr","year":"2002","unstructured":"Zerr I, Poser S (2002) Clinical diagnosis and differential diagnosis of CJD and vCJD. APMIS 110(1):88\u201398","journal-title":"APMIS"},{"issue":"5","key":"5112_CR17","doi-asserted-by":"publisher","first-page":"afae086","DOI":"10.1093\/ageing\/afae086","volume":"53","author":"EA McDermott","year":"2024","unstructured":"McDermott EA, Watson N, Tam J, Centola J, Kurucu King H, Mackenzie J et al (2024) Sporadic Creutzfeldt-Jakob disease in adults over 80 years: a 10-year review of United Kingdom surveillance. Age Ageing. 53(5):afae086","journal-title":"Age Ageing."},{"key":"5112_CR18","unstructured":"[Clinical features of familial Creutzfeldt-Jakob disease and the E200K mutation in Spain]. | Semantic Scholar [Internet]. [citado 22 de diciembre de 2024]. Disponible en: https:\/\/www.semanticscholar.org\/paper\/%5BClinical-features-of-familial-Creutzfeldt-Jakob-in-Morgado-Linares-Ruiz-Pe%C3%B1a\/681dbceea67e6f550a7c1b2a749a91dd7dcde01a"},{"issue":"4","key":"5112_CR19","first-page":"185","volume":"13","author":"H Seno","year":"1994","unstructured":"Seno H, Ishino H, Inagaki T et al (1994) Familial Creutzfeldt-Jakob disease: three autopsy cases of the panencephalopathic type. Clin Neuropathol 13(4):185\u2013191","journal-title":"Clin Neuropathol"},{"issue":"6","key":"5112_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1600-0404.1993.tb04139.x","volume":"87","author":"J Kovanen","year":"1993","unstructured":"Kovanen J (1993) Clinical characteristics of familial and sporadic Creutzfeldt-Jakob disease in Finland. Acta Neurol Scand junio de 87(6):469\u2013474","journal-title":"Acta Neurol Scand junio de"},{"issue":"4","key":"5112_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00005792-199707000-00001","volume":"76","author":"Z Meiner","year":"1997","unstructured":"Meiner Z, Gabizon R, Prusiner SB (1997) Familial Creutzfeldt-Jakob disease: codon 200 prion disease in Libyan Jews. Medicine 76(4):227","journal-title":"Medicine"},{"issue":"3","key":"5112_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/brain\/104.3.535","volume":"104","author":"CL Masters","year":"1981","unstructured":"Masters CL, Gajdusek DC, Gibbs CJ (1981) The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer\u2019s disease. Brain 104(3):535\u2013558","journal-title":"Brain"},{"issue":"8","key":"5112_CR23","first-page":"1438","volume":"65","author":"N Sanjo","year":"2007","unstructured":"Sanjo N (2007) Acquired Creutzfeldt-Jakob disease (CJD)\u2013Kuru, iatrogenic CJD, variant CJD. Nihon Rinsho 65(8):1438\u20131445","journal-title":"Nihon Rinsho"},{"issue":"6","key":"5112_CR24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3201\/eid1806.120116","volume":"18","author":"P Brown","year":"2012","unstructured":"Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG et al (2012) Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 18(6):901\u2013907","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"5112_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/ageing\/31.1.7","volume":"31","author":"C Henry","year":"2002","unstructured":"Henry C (2002) Creutzfeldt-Jakob disease in elderly people. Age Ageing. 31(1):7\u201310","journal-title":"Age Ageing."},{"key":"5112_CR26","unstructured":"atrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study. | Semantic Scholar [Internet]. [citado 22 de diciembre de 2024]. Disponible en: https:\/\/www.semanticscholar.org\/paper\/Iatrogenic-Creutzfeldt-Jakob-disease-in-three-a-Villemeur-Gelot\/43807f8fa58bb8b95104ade79414adfffcdfa159"},{"issue":"3","key":"5112_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1750-3639.2003.tb00025.x","volume":"13","author":"HA Kretzschmar","year":"2006","unstructured":"Kretzschmar HA, Sethi S, F\u00f6ldv\u00e1ri Z, Windl O, Querner V, Zerr I et al (2006) Iatrogenic Creutzfeldt-Jakob disease with florid plaques. Brain Pathol 13(3):245\u20139","journal-title":"Brain Pathol"},{"issue":"3","key":"5112_CR28","doi-asserted-by":"publisher","first-page":"651S","DOI":"10.1093\/ajcn\/78.3.651S","volume":"78","author":"CR Trevitt","year":"2003","unstructured":"Trevitt CR, Singh PN (2003) Variant Creutzfeldt-Jakob disease: pathology, epidemiology, and public health implications. Am J Clin Nutrition 78(3):651S-656S","journal-title":"Am J Clin Nutrition"},{"issue":"3","key":"5112_CR29","first-page":"217","volume":"2","author":"GA Mackay","year":"2011","unstructured":"Mackay GA, Knight RS, Ironside JW (2011) The molecular epidemiology of variant CJD. Int J Mol Epidemiol Genet 2(3):217\u201327","journal-title":"Int J Mol Epidemiol Genet"},{"issue":"3","key":"5112_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/rmv.345","volume":"12","author":"C Henry","year":"2002","unstructured":"Henry C, Knight R (2002) Clinical features of variant Creutzfeldt-Jakob disease. Rev Med Virology 12(3):143\u2013150","journal-title":"Rev Med Virology"},{"key":"5112_CR31","doi-asserted-by":"crossref","unstructured":"Will RG, Ward HJT. Clinical features of variant Creutzfeldt-Jakob disease. In: Harris DA (ed) Mad cow disease and related spongiform encephalopathies [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2004 [citado 22 de diciembre de 2024]. p. 121\u201332. (Compans RW, Cooper MD, Honjo T, Koprowski H, Melchers F, Oldstone MBA, et al. Current Topics in Microbiology and Immunology; vol. 284). Disponible en: http:\/\/link.springer.com\/10.1007\/978-3-662-08441-0_5","DOI":"10.1007\/978-3-662-08441-0_5"},{"issue":"2","key":"5112_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/archneurol.2008.533","volume":"66","author":"BS Appleby","year":"2009","unstructured":"Appleby BS, Appleby KK, Crain BJ, Onyike CU, Wallin MT, Rabins PV (2009) Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants. Archives Neurology. 66(2):208\u201315","journal-title":"Archives Neurology."},{"key":"5112_CR33","doi-asserted-by":"crossref","unstructured":"Ironside JW (1998) Neuropathological findings in new variant CJD and experimental transmission of BSE. FEMS Immunol Med Microbiol 21(2):91\u20135. \u2192 33","DOI":"10.1016\/S0928-8244(98)00020-0"},{"key":"5112_CR34","doi-asserted-by":"crossref","unstructured":"Kishida H, Ueda N, Tanaka F (2023) The advances in the early and accurate diagnosis of Creutzfeldt\u2013Jakob disease and other prion diseases: where are we today? Expert Review of Neurotherapeutics 23(9):803\u201317. -> 33","DOI":"10.1080\/14737175.2023.2246653"},{"key":"5112_CR35","unstructured":"Clinical diagnosis of human prion disease. | Semantic Scholar [Internet]. [citado 22 de diciembre de 2024]. Disponible en: https:\/\/www.semanticscholar.org\/paper\/Clinical-diagnosis-of-human-prion-disease.-Knight\/0d3c53416bca6249613bc3c123b7539a99b126ad"},{"issue":"6","key":"5112_CR36","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bsheal.2021.09.003","volume":"3","author":"J Wu","year":"2021","unstructured":"Wu J, Chen D, Shi Q, Dong X (2021) Protein amplification technology: new advances in human prion disease diagnosis. Biosafety Health 3(6):325\u201332","journal-title":"Biosafety Health"},{"key":"5112_CR37","doi-asserted-by":"crossref","unstructured":"Cazzaniga FA, Bistaffa E, De Luca CMG, Bufano G, Indaco A, Giaccone G, et al (2021) Sporadic Creutzfeldt-Jakob disease: real-time quaking induced conversion (RT-QuIC) assay represents a major diagnostic advance. Eur J Histochem [Internet]. [citado 22 de diciembre de 2024];65(s1). Disponible en: https:\/\/ejh.it\/index.php\/ejh\/article\/view\/3298","DOI":"10.4081\/ejh.2021.3298"},{"issue":"8","key":"5112_CR38","doi-asserted-by":"publisher","first-page":"a018226","DOI":"10.1101\/cshperspect.a018226","volume":"8","author":"TD Pollard","year":"2016","unstructured":"Pollard TD (2016) Actin and actin-binding proteins. Cold Spring Harbor Perspectives In Biol 8(8):a018226. https:\/\/doi.org\/10.1101\/cshperspect.a018226","journal-title":"Cold Spring Harbor Perspectives In Biol"},{"key":"5112_CR39","unstructured":"Cooper GM (2000) Structure and organization of actin filaments [Internet]. The Cell - NCBI Bookshelf. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK9908\/#:~:text=Individual%20action%20molecules%20are%20globular,actin"},{"key":"5112_CR40","doi-asserted-by":"publisher","unstructured":"Goode BL, Eskin J, Shekhar S (2023) Mechanisms of actin disassembly and turnover. J Cell Biol [Internet] 222(12). https:\/\/doi.org\/10.1083\/jcb.202309021","DOI":"10.1083\/jcb.202309021"},{"key":"5112_CR41","doi-asserted-by":"publisher","unstructured":"Bai Y, Zhao F, Wu T, Chen F, Pang X (2023) Actin polymerization and depolymerization in developing vertebrates. Frontiers In Physiology [Internet]. 14. https:\/\/doi.org\/10.3389\/fphys.2023.1213668","DOI":"10.3389\/fphys.2023.1213668"},{"issue":"19","key":"5112_CR42","doi-asserted-by":"publisher","first-page":"10727","DOI":"10.3390\/ijms221910727","volume":"22","author":"JN Namme","year":"2021","unstructured":"Namme JN, Bepari AK, Takebayashi H (2021) Cofilin signaling in the CNS physiology and neurodegeneration. Int J Mol Sci 22(19):10727. https:\/\/doi.org\/10.3390\/ijms221910727","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5112_CR43","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4161\/bioa.22549","volume":"2","author":"LN Munsie","year":"2012","unstructured":"Munsie LN, Truant R (2012) The role of the cofilin-actin rod stress response in neurodegenerative diseases uncovers potential new drug targets. BioArchitecture 2(6):204\u20138. https:\/\/doi.org\/10.4161\/bioa.22549","journal-title":"BioArchitecture"},{"issue":"20","key":"5112_CR44","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/nejm199205143262006","volume":"326","author":"FH Epstein","year":"1992","unstructured":"Epstein FH, Lee WM, Galbraith RM (1992) The extracellular actin-scavenger system and actin toxicity. New England J Med 326(20):1335\u201341. https:\/\/doi.org\/10.1056\/nejm199205143262006","journal-title":"New England J Med"},{"issue":"6651","key":"5112_CR45","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1126\/science.adg6812","volume":"380","author":"PJ Carman","year":"2023","unstructured":"Carman PJ, Barrie KR, Rebowski G, Dominguez R (2023) Structures of the free and capped ends of the actin filament. Science 380(6651):1287\u201392. https:\/\/doi.org\/10.1126\/science.adg6812","journal-title":"Science"},{"issue":"2","key":"5112_CR46","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0092-8674(83)90382-3","volume":"34","author":"EM Bonder","year":"1983","unstructured":"Bonder EM, Fishkind DJ, Mooseker MS (1983) Direct measurement of critical concentrations and assembly rate constants at the two ends of an actin filament. Cell 34(2):491\u2013501. https:\/\/doi.org\/10.1016\/0092-8674(83)90382-3","journal-title":"Cell"},{"issue":"2","key":"5112_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1083\/jcb.101.2.597","volume":"101","author":"YL Wang","year":"1985","unstructured":"Wang YL (1985) Exchange of actin subunits at the leading edge of living fibroblasts: possible role of treadmilling. J Cell Biol 101(2):597\u2013602. https:\/\/doi.org\/10.1083\/jcb.101.2.597","journal-title":"J Cell Biol"},{"issue":"3\u20134","key":"5112_CR48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/cm.21586","volume":"77","author":"R Pinto-Costa","year":"2019","unstructured":"Pinto-Costa R, Sousa MM (2019) Profilin as a dual regulator of actin and microtubule dynamics. Cytoskeleton 77(3\u20134):76\u201383. https:\/\/doi.org\/10.1002\/cm.21586","journal-title":"Cytoskeleton"},{"key":"5112_CR49","doi-asserted-by":"crossref","unstructured":"Fregozo CS, Vega MIP (2011) Participaci\u00f3n de las prote\u00ednas de uni\u00f3n a la actina y v\u00edas de se\u00f1alizaci\u00f3n asociadas a la formaci\u00f3n y mantenimiento de las espinas dendr\u00edticas. Neurolog\u00eda [Internet]. 27(7):421\u201331. Available at: https:\/\/www.elsevier.es\/es-revista-neurologia-295-articulo-participacion-las-proteinas-union-actina-S0213485311004142","DOI":"10.1016\/j.nrl.2011.10.005"},{"key":"5112_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pneurobio.2016.04.007","volume":"141","author":"J Eira","year":"2016","unstructured":"Eira J, Silva CS, Sousa MM, Liz MA (2016) The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders. Progress Neurobiol 141:61\u201382. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.04.007","journal-title":"Progress Neurobiol"},{"issue":"26","key":"5112_CR51","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1523\/jneurosci.0844-18.2018","volume":"38","author":"HS Moghaddam","year":"2018","unstructured":"Moghaddam HS, Aarabi MH (2018) A\u03b2-mediated dysregulation of F-actin nanoarchitecture leads to loss of dendritic spines and Alzheimer\u2019s disease-related cognitive impairments. J Neurosci 38(26):5840\u20132. https:\/\/doi.org\/10.1523\/jneurosci.0844-18.2018","journal-title":"J Neurosci"},{"issue":"5","key":"5112_CR52","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1523\/jneurosci.2127-17.2017","volume":"38","author":"RP Kommaddi","year":"2017","unstructured":"Kommaddi RP, Das D, Karunakaran S, Nanguneri S, Bapat D, Ray A et al (2017) A\u03b2 mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer\u2019s disease. J Neurosci 38(5):1085\u201399. https:\/\/doi.org\/10.1523\/jneurosci.2127-17.2017","journal-title":"J Neurosci"},{"key":"5112_CR53","doi-asserted-by":"crossref","unstructured":"Witte H, Bradke F (2008) The role of the cytoskeleton during neuronal polarization. Current Opinion In Neurobiology [Internet]. 18(5):479\u201387. https:\/\/pubmed.ncbi.nlm.nih.gov\/18929658\/","DOI":"10.1016\/j.conb.2008.09.019"},{"issue":"1","key":"5112_CR54","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1146\/annurev.cellbio.18.031802.150501","volume":"18","author":"L Luo","year":"2002","unstructured":"Luo L (2002) Actin cytoskeleton regulation in neuronal morphogenesis and structural plasticity. Annual Rev Cell Dev Biol 18(1):601\u201335. https:\/\/doi.org\/10.1146\/annurev.cellbio.18.031802.150501","journal-title":"Annual Rev Cell Dev Biol"},{"issue":"1","key":"5112_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mcn.2010.08.015","volume":"46","author":"LC Kapitein","year":"2010","unstructured":"Kapitein LC, Hoogenraad CC (2010) Which way to go? Cytoskeletal organization and polarized transport in neurons. Moll Cellular Neurosci 46(1):9\u201320. https:\/\/doi.org\/10.1016\/j.mcn.2010.08.015","journal-title":"Moll Cellular Neurosci"},{"issue":"1","key":"5112_CR56","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/diseases11010030","volume":"11","author":"MR Ajmal","year":"2023","unstructured":"Ajmal MR (2023) Protein misfolding and aggregation in proteinopathies: causes, mechanism and cellular response. Diseases 11(1):30. https:\/\/doi.org\/10.3390\/diseases11010030","journal-title":"Diseases"},{"issue":"7","key":"5112_CR57","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nrm3609","volume":"14","author":"JJ Bravo-Cordero","year":"2013","unstructured":"Bravo-Cordero JJ, Magalhaes MAO, Eddy RJ, Hodgson L, Condeelis J (2013) Functions of cofilin in cell locomotion and invasion. Nat Rev Mol Cell Biol 14(7):405\u201315. https:\/\/doi.org\/10.1038\/nrm3609","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"5112_CR58","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bbrc.2020.08.041","volume":"532","author":"JB Heidings","year":"2020","unstructured":"Heidings JB, Demosthene B, Merlino TR, Castaneda N, Kang EH (2020) Gelsolin-mediated actin filament severing in crowded environments. Biochem Biophys Res Comm 532(4):548\u201354. https:\/\/doi.org\/10.1016\/j.bbrc.2020.08.041","journal-title":"Biochem Biophys Res Comm"},{"key":"5112_CR59","doi-asserted-by":"publisher","unstructured":"Feldt J, Schicht M, Garreis F, Welss J, Schneider UW, Paulsen F (2018) Structure, regulation and related diseases of the actin-binding protein gelsolin. Expert Rev Mol Med 20. https:\/\/doi.org\/10.1017\/erm.2018.7","DOI":"10.1017\/erm.2018.7"},{"key":"5112_CR60","doi-asserted-by":"crossref","unstructured":"Piktel E, Levental I, Durna\u015b B, Janmey P, Bucki R (2018) Plasma gelsolin: indicator of inflammation and its potential as a diagnostic tool and therapeutic target. International Journal Of Molecular Sciences [Internet]. 19(9):2516. Available at: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6164782\/","DOI":"10.3390\/ijms19092516"},{"issue":"1","key":"5112_CR61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/13506129809007291","volume":"5","author":"S Kiuru","year":"1998","unstructured":"Kiuru S (1998) Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid 5(1):55\u201366. https:\/\/doi.org\/10.3109\/13506129809007291","journal-title":"Amyloid"},{"issue":"3","key":"5112_CR62","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ajmg.1320420321","volume":"42","author":"M Haltia","year":"1992","unstructured":"Haltia M, Levy E, Meretoja J, Fernandez-Madrid I, Koivunen O, Frangione B (1992) Gelsolin gene mutation\u2014at codon 187\u2014in familial amyloidosis, Finnish: DNA-diagnostic assay. Am J Med Gen 42(3):357\u20139. https:\/\/doi.org\/10.1002\/ajmg.1320420321","journal-title":"Am J Med Gen"},{"key":"5112_CR63","doi-asserted-by":"crossref","unstructured":"Ji L, Chauhan V, Mehta P, Wegiel J, Mehta S, Chauhan A (2010) Relationship between proteolytically cleaved gelsolin and levels of amyloid-\u0392 protein in the brains of down syndrome subjects. Journal of Alzheimer S Disease [Internet]. 22(2):609\u201317. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20847428\/","DOI":"10.3233\/JAD-2010-101029"},{"issue":"1","key":"5112_CR64","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3233\/jad-2009-1127","volume":"18","author":"L Ji","year":"2009","unstructured":"Ji L, Chauhan A, Wegiel J, Essa MM, Chauhan V (2009) Gelsolin is proteolytically cleaved in the brains of individuals with Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 18(1):105\u201311. https:\/\/doi.org\/10.3233\/jad-2009-1127","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"5112_CR65","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3109\/10409238.2012.661401","volume":"47","author":"JP Solomon","year":"2012","unstructured":"Solomon JP, Page LJ, Balch WE, Kelly JW (2012) Gelsolin amyloidosis: genetics, biochemistry, pathology and possible strategies for therapeutic intervention. Critical Rev Biochem Mol Biol 47(3):282\u201396. https:\/\/doi.org\/10.3109\/10409238.2012.661401","journal-title":"Critical Rev Biochem Mol Biol"},{"key":"5112_CR66","doi-asserted-by":"publisher","unstructured":"Kiuru S, Salonen O, Haltia M (1999) Gelsolin-related spinal and cerebral amyloid angiopathy. Ann Neurol [Internet]. 45(3):305\u201311. Available from: https:\/\/doi.org\/10.1002\/1531-8249(199903)45:3<305::aid-ana5>3.0.co;2-e","DOI":"10.1002\/1531-8249(199903)45:3<305::aid-ana5>3.0.co;2-e"},{"issue":"5","key":"5112_CR67","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.jmb.2006.10.102","volume":"365","author":"D Pavlov","year":"2006","unstructured":"Pavlov D, Muhlrad A, Cooper J, Wear M, Reisler E (2006) Actin filament severing by cofilin. J Mol Biol 365(5):1350\u20138. https:\/\/doi.org\/10.1016\/j.jmb.2006.10.102","journal-title":"J Mol Biol"},{"issue":"5","key":"5112_CR68","doi-asserted-by":"publisher","first-page":"reviews3007.1","DOI":"10.1186\/gb-2002-3-5-reviews3007","volume":"3","author":"SK Maciver","year":"2002","unstructured":"Maciver SK, Hussey PJ (2002) The ADF\/cofilin family: actin-remodeling proteins. Genome Biology 3(5):reviews3007.1. https:\/\/doi.org\/10.1186\/gb-2002-3-5-reviews3007","journal-title":"Genome Biology"},{"issue":"4","key":"5112_CR69","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2174\/1871527314666150225144052","volume":"14","author":"B Chen","year":"2015","unstructured":"Chen B, Wang Y (2015) Cofilin rod formation in neurons impairs neuronal structure and function. CNS NeurolDisord - Drug Targets 14(4):554\u201360. https:\/\/doi.org\/10.2174\/1871527314666150225144052","journal-title":"CNS NeurolDisord - Drug Targets"},{"issue":"4","key":"5112_CR70","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.tcb.2010.01.001","volume":"20","author":"BW Bernstein","year":"2010","unstructured":"Bernstein BW, Bamburg JR (2010) ADF\/Cofilin: a functional node in cell biology. Trends Cell Biol 20(4):187\u201395. https:\/\/doi.org\/10.1016\/j.tcb.2010.01.001","journal-title":"Trends Cell Biol"},{"issue":"1","key":"5112_CR71","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/bf02700622","volume":"35","author":"MT Maloney","year":"2007","unstructured":"Maloney MT, Bamburg JR (2007) Cofilin-mediated neurodegeneration in Alzheimer\u2019s disease and other amyloidopathies. Mol Neurobiol 35(1):21\u201343. https:\/\/doi.org\/10.1007\/bf02700622","journal-title":"Mol Neurobiol"},{"issue":"6","key":"5112_CR72","doi-asserted-by":"publisher","first-page":"375","DOI":"10.4161\/pri.35504","volume":"8","author":"KP Walsh","year":"2014","unstructured":"Walsh KP, Kuhn TB, Bamburg JR (2014) Cellular prion protein: a co-receptor mediating neuronal cofilin-actin rod formation induced by \u03b2-amyloid and proinflammatory cytokines. Prion 8(6):375\u201380. https:\/\/doi.org\/10.4161\/pri.35504","journal-title":"Prion"},{"key":"5112_CR73","doi-asserted-by":"publisher","unstructured":"Wurz AI, Schulz AM, O\u2019Bryant CT, Sharp JF, Hughes RM (2022) Cytoskeletal dysregulation and neurodegenerative disease: formation, monitoring, and inhibition of cofilin-actin rods. Front Cellular Neurosci [Internet]. 16. https:\/\/doi.org\/10.3389\/fncel.2022.982074","DOI":"10.3389\/fncel.2022.982074"},{"issue":"2","key":"5112_CR74","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/cells13020188","volume":"13","author":"F Shehjar","year":"2024","unstructured":"Shehjar F, Almarghalani DA, Mahajan R, Hasan SAM, Shah ZA (2024) The multifaceted role of cofilin in neurodegeneration and stroke: insights into pathogenesis and targeting as a therapy. Cells 13(2):188. https:\/\/doi.org\/10.3390\/cells13020188","journal-title":"Cells"},{"issue":"7","key":"5112_CR75","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/brainsci11070954","volume":"11","author":"T Lape\u00f1a-Luz\u00f3n","year":"2021","unstructured":"Lape\u00f1a-Luz\u00f3n T, Rodr\u00edguez LR, Beltran-Beltran V, Benet\u00f3 N, Pallard\u00f3 FV, Gonzalez-Cabo P (2021) Cofilin and neurodegeneration: new functions for an old but gold protein. Brain Sciences 11(7):954. https:\/\/doi.org\/10.3390\/brainsci11070954","journal-title":"Brain Sciences"},{"key":"5112_CR76","doi-asserted-by":"publisher","unstructured":"Zafar S, Younas N, Sheikh N, Tahir W, Shafiq M, Schmitz M, et al (2017) Cytoskeleton-associated risk modifiers involved in early and rapid progression of sporadic Creutzfeldt-Jakob disease. Mol Neurobiol [Internet]. Available at: https:\/\/doi.org\/10.1007\/s12035-017-0589-0","DOI":"10.1007\/s12035-017-0589-0"},{"key":"5112_CR77","doi-asserted-by":"publisher","unstructured":"Zhong Z, Grasso L, Sibilla C, Stevens TJ, Barry N, Bertolotti A (2018) Prion\u2010like protein aggregates exploit the RHO GTPase to cofilin\u20101 signaling pathway to enter cells. The EMBO J 37(6). Available at: https:\/\/doi.org\/10.15252\/embj.201797822","DOI":"10.15252\/embj.201797822"},{"issue":"10","key":"5112_CR78","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.3390\/cells10102726","volume":"10","author":"J Bamburg","year":"2021","unstructured":"Bamburg J, Minamide L, Wiggan O, Tahtamouni L, Kuhn T (2021) Cofilin and actin dynamics: multiple modes of regulation and their impacts in neuronal development and degeneration. Cells 10(10):2726. https:\/\/doi.org\/10.3390\/cells10102726","journal-title":"Cells"},{"key":"5112_CR79","doi-asserted-by":"publisher","unstructured":"Kounakis K, Tavernarakis N (2019) The cytoskeleton as a modulator of aging and neurodegeneration. Adv Exp MedBiol 227\u201345. Available from: https:\/\/doi.org\/10.1007\/978-3-030-25650-0_12","DOI":"10.1007\/978-3-030-25650-0_12"},{"issue":"16","key":"5112_CR80","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.3390\/cells11162499","volume":"11","author":"P Alberti","year":"2022","unstructured":"Alberti P, Semperboni S, Cavaletti G, Scuteri A (2022) Neurons: the interplay between cytoskeleton, ion channels\/transporters and mitochondria. Cells 11(16):2499. https:\/\/doi.org\/10.3390\/cells11162499","journal-title":"Cells"},{"issue":"2","key":"5112_CR81","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1113\/jp278702","volume":"599","author":"JE Shaw","year":"2020","unstructured":"Shaw JE, Koleske AJ (2020) Functional interactions of ion channels with the actin cytoskeleton: does coupling to dynamic actin regulate NMDA receptors? J Physiol 599(2):431\u201341. https:\/\/doi.org\/10.1113\/jp278702","journal-title":"J Physiol"},{"issue":"21","key":"5112_CR82","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.1523\/jneurosci.21-21-08464.2001","volume":"21","author":"S Lei","year":"2001","unstructured":"Lei S, Czerwinska E, Czerwinski W, Walsh MP, MacDonald JF (2001) Regulation of NMDA receptor activity by F-actin and myosin light chain kinase. J Neurosci. 21(21):8464\u201372. https:\/\/doi.org\/10.1523\/jneurosci.21-21-08464.2001","journal-title":"J Neurosci."},{"issue":"10","key":"5112_CR83","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1134\/s0006297918100036","volume":"83","author":"DA Sibarov","year":"2018","unstructured":"Sibarov DA, Antonov SM (2018) Calcium-dependent desensitization of NMDA receptors. Biochemistry (Moscow) 83(10):1173\u201383. https:\/\/doi.org\/10.1134\/s0006297918100036","journal-title":"Biochemistry (Moscow)"},{"issue":"5","key":"5112_CR84","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0896-6273(93)90197-y","volume":"10","author":"C Rosenmund","year":"1993","unstructured":"Rosenmund C, Westbrook GL (1993) Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron 10(5):805\u201314. https:\/\/doi.org\/10.1016\/0896-6273(93)90197-y","journal-title":"Neuron"},{"key":"5112_CR85","doi-asserted-by":"publisher","unstructured":"Hanley JG (2014) Actin-dependent mechanisms in AMPA receptor trafficking. Frontiers In Cellular Neuroscience 8. Available at: https:\/\/doi.org\/10.3389\/fncel.2014.00381","DOI":"10.3389\/fncel.2014.00381"},{"issue":"2","key":"5112_CR86","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/jnc.14658","volume":"149","author":"R Rosas-Hern\u00e1ndez","year":"2018","unstructured":"Rosas-Hern\u00e1ndez R, Basti\u00e1n Y, Tello AJ, Ram\u00edrez-Sa\u00edto \u00c1, Garc\u00eda DME, Pozos-Guill\u00e9n A et al (2018) AMPA receptors modulate the reorganization of F-actin in Bergmann glia cells through the activation of RhoA. J Neurochem 149(2):242\u201354. https:\/\/doi.org\/10.1111\/jnc.14658","journal-title":"J Neurochem"},{"issue":"1","key":"5112_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/ijms25010111","volume":"25","author":"YY Cao","year":"2023","unstructured":"Cao YY, Wu LL, Li XN, Yuan YL, Zhao WW, Qi JX et al (2023) Molecular mechanisms of AMPA receptor trafficking in the nervous system. Int J Mol Sci 25(1):111. https:\/\/doi.org\/10.3390\/ijms25010111","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5112_CR88","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/ijms21030908","volume":"21","author":"S Pelucchi","year":"2020","unstructured":"Pelucchi S, Stringhi R, Marcello E (2020) Dendritic Spines in Alzheimer\u2019s disease: how the actin cytoskeleton contributes to synaptic failure. Int J Mol Sci 21(3):908. https:\/\/doi.org\/10.3390\/ijms21030908","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5112_CR89","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00401-003-0732-z","volume":"106","author":"I Ferrer","year":"2003","unstructured":"Ferrer I, Puig B (2003) GluR2\/3, NMDA?1 and GABAA receptors in Creutzfeldt-Jakob disease. Acta Neuropathologica 106(4):311\u20138. https:\/\/doi.org\/10.1007\/s00401-003-0732-z","journal-title":"Acta Neuropathologica"},{"issue":"12","key":"5112_CR90","doi-asserted-by":"publisher","first-page":"645","DOI":"10.5483\/bmbrep.2023-0151","volume":"56","author":"S Cha","year":"2023","unstructured":"Cha S, Kim MY (2023) The role of cellular prion protein in immune system. BMB Reports 56(12):645\u201350. https:\/\/doi.org\/10.5483\/bmbrep.2023-0151","journal-title":"BMB Reports"},{"issue":"2","key":"5112_CR91","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/21541248.2017.1364831","volume":"11","author":"EK Choi","year":"2017","unstructured":"Choi EK, Kim JG, Kim HJ, Cho JY, Jeong H, Park Y et al (2017) Regulation of RhoA GTPase and novel target proteins for ROCK. Small GTPases 11(2):95\u2013102. https:\/\/doi.org\/10.1080\/21541248.2017.1364831","journal-title":"Small GTPases"},{"issue":"1","key":"5112_CR92","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.phrs.2005.09.002","volume":"53","author":"L Re","year":"2005","unstructured":"Re L, Rossini F, Re F, Bordicchia M, Mercanti A, Fernandez O et al (2005) Prion protein potentiates acetylcholine release at the neuromuscular junction. Pharmacol Res 53(1):62\u20138. https:\/\/doi.org\/10.1016\/j.phrs.2005.09.002","journal-title":"Pharmacol Res"},{"issue":"3","key":"5112_CR93","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1046\/j.1471-4159.2003.01882.x","volume":"86","author":"N Vassallo","year":"2003","unstructured":"Vassallo N, Herms J (2003) Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 86(3):538\u201344. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01882.x","journal-title":"J Neurochem"},{"issue":"5660","key":"5112_CR94","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1126\/science.1093133","volume":"303","author":"A Rustom","year":"2004","unstructured":"Rustom A, Saffrich R, Markovic I, Walther P, Gerdes HH (2004) Nanotubular highways for intercellular organelle transport. Science 303(5660):1007\u201310. https:\/\/doi.org\/10.1126\/science.1093133","journal-title":"Science"},{"issue":"1","key":"5112_CR95","doi-asserted-by":"publisher","first-page":"e27934","DOI":"10.4161\/cib.27934","volume":"7","author":"MW Austefjord","year":"2014","unstructured":"Austefjord MW, Gerdes HH, Wang X (2014) Tunneling nanotubes. Comm Integrative Biol 7(1):e27934. https:\/\/doi.org\/10.4161\/cib.27934","journal-title":"Comm Integrative Biol"},{"issue":"6","key":"5112_CR96","doi-asserted-by":"publisher","first-page":"160057","DOI":"10.1098\/rsob.160057","volume":"6","author":"A Rustom","year":"2016","unstructured":"Rustom A (2016) The missing link: does tunnelling nanotube-based supercellularity provide a new understanding of chronic and lifestyle diseases? Open Biology 6(6):160057. https:\/\/doi.org\/10.1098\/rsob.160057","journal-title":"Open Biology"},{"issue":"5","key":"5112_CR97","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/19336896.2016.1223003","volume":"10","author":"S Abounit","year":"2016","unstructured":"Abounit S, Wu JW, Duff K, Victoria GS, Zurzolo C (2016) Tunneling nanotubes: a possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases. Prion 10(5):344\u201351","journal-title":"Prion"},{"key":"5112_CR98","doi-asserted-by":"crossref","unstructured":"Zhu S, Victoria GS, Marzo L, Ghosh R, Zurzolo C (2015) Prion aggregates transfer through tunneling nanotubes in endocytic vesicles. Prion [Internet]. 9(2):125\u201335. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/25996400\/","DOI":"10.1080\/19336896.2015.1025189"},{"key":"5112_CR99","doi-asserted-by":"crossref","unstructured":"Ranzinger J, Rustom A, Abel M, Leyh J, Kihm L, Witkowski M, et al (2011) Nanotube action between human mesothelial cells reveals novel aspects of inflammatory responses. PLoS ONE 6(12):e29537. https:\/\/pubmed.ncbi.nlm.nih.gov\/22216308\/","DOI":"10.1371\/journal.pone.0029537"},{"issue":"1","key":"5112_CR100","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1212\/wnl.58.1.127","volume":"58","author":"L Minghetti","year":"2002","unstructured":"Minghetti L, Cardone F, Greco A, Puopolo M, Levi G, Green AJ, Knight R, Pocchiari M (2002) Increased CSF levels of prostaglandin E(2) in variant Creutzfeldt-Jakob disease. Neurology 58(1):127\u2013129. https:\/\/doi.org\/10.1212\/wnl.58.1.127","journal-title":"Neurology"},{"issue":"2","key":"5112_CR101","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1006\/nbdi.2002.0496","volume":"10","author":"S Arlt","year":"2002","unstructured":"Arlt S, Kontush A, Zerr I, Buhmann C, Jacobi C, Schr\u00f6ter A et al (2002) Increased lipid peroxidation in cerebrospinal fluid and plasma from patients with Creutzfeldt-Jakob disease. Neurobiol Dis 10(2):150\u2013156","journal-title":"Neurobiol Dis"},{"issue":"1","key":"5112_CR102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bbrc.2011.12.098","volume":"418","author":"FR Bertuchi","year":"2012","unstructured":"Bertuchi FR, Bourgeon DMG, Landemberger MC, Martins VR, Cerchiaro G (2012) PrPC displays an essential protective role from oxidative stress in an astrocyte cell line derived from PrPC knockout mice. Biochem Biophys Res Commun. 418(1):27\u201332","journal-title":"Biochem Biophys Res Commun."},{"key":"5112_CR103","unstructured":"Antioxidant activity related to copper binding of native prion protein - Brown - 2001 - Journal of Neurochemistry - Wiley Online Library [Internet]. [citado 17 de diciembre de 2024]. Disponible en: https:\/\/onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1046\/j.1471-4159.2001.00009.x?download=true"},{"issue":"11","key":"5112_CR104","doi-asserted-by":"publisher","first-page":"9064","DOI":"10.1074\/jbc.M211830200","volume":"278","author":"W Rachidi","year":"2003","unstructured":"Rachidi W, Vilette D, Guiraud P, Arlotto M, Riondel J, Laude H et al (2003) Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J Biol Chem 278(11):9064\u20139072","journal-title":"J Biol Chem"},{"issue":"4","key":"5112_CR105","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/cdd.2010.147","volume":"18","author":"Y Wang","year":"2011","unstructured":"Wang Y, Cui J, Sun X, Zhang Y (2011) Tunneling-nanotube development in astrocytes depends on p53 activation. Cell Death Differ 18(4):732\u2013742","journal-title":"Cell Death Differ"},{"issue":"1","key":"5112_CR106","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00018-021-04040-0","volume":"79","author":"A Raghavan","year":"2022","unstructured":"Raghavan A, Rao P, Neuzil J, Pountney DL, Nath S (2022) Oxidative stress and Rho GTPases in the biogenesis of tunnelling nanotubes: implications in disease and therapy. Cell Mol Life Sci 79(1):36","journal-title":"Cell Mol Life Sci"},{"issue":"Supplement_7","key":"5112_CR107","doi-asserted-by":"publisher","first-page":"S522","DOI":"10.1093\/infdis\/jiad400","volume":"228","author":"MA Djurkovic","year":"2023","unstructured":"Djurkovic MA, Leavitt CG, Arnett E, Kriachun V, Mart\u00ednez-Sobrido L, Titone R et al (2023) Ebola virus uses tunneling nanotubes as an alternate route of dissemination. J Infect Dis 228(Supplement_7):S522-35. https:\/\/doi.org\/10.1093\/infdis\/jiad400","journal-title":"J Infect Dis"},{"issue":"2","key":"5112_CR108","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/biom12020313","volume":"12","author":"G Bertacchi","year":"2022","unstructured":"Bertacchi G, Posch W, Wilflingseder D (2022) HIV-1 trans infection via TNTs is impeded by targeting C5aR. Biomolecules 12(2):313. https:\/\/doi.org\/10.3390\/biom12020313","journal-title":"Biomolecules"},{"issue":"19","key":"5112_CR109","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1242\/jcs.129239","volume":"126","author":"K Gousset","year":"2013","unstructured":"Gousset K, Marzo L, Commere PH, Zurzolo C (2013) Myo10 is a key regulator of TNT formation in neuronal cells. J Cell Sci 126(19):4424\u201335. https:\/\/doi.org\/10.1242\/jcs.129239","journal-title":"J Cell Sci"},{"key":"5112_CR110","doi-asserted-by":"publisher","first-page":"105541","DOI":"10.1016\/j.phrs.2021.105541","volume":"170","author":"XT Wang","year":"2021","unstructured":"Wang XT, Sun H, Chen NH, Yuan YH (2021) Tunneling nanotubes: a novel pharmacological target for neurodegenerative diseases? Pharmacological Res 170:105541","journal-title":"Pharmacological Res"},{"issue":"5","key":"5112_CR111","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/path.2145","volume":"211","author":"L Vella","year":"2007","unstructured":"Vella L, Sharples R, Lawson V, Masters C, Cappai R, Hill A (2007) Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathology 211(5):582\u201390. https:\/\/doi.org\/10.1002\/path.2145","journal-title":"J Pathology"},{"issue":"18","key":"5112_CR112","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1016\/j.bmc.2013.12.046","volume":"22","author":"KR Brunden","year":"2014","unstructured":"Brunden KR, Trojanowski JQ, Smith AB, Lee VMY, Ballatore C (2014) Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease. Bioorganic Med Chem 22(18):5040\u20139. https:\/\/doi.org\/10.1016\/j.bmc.2013.12.046","journal-title":"Bioorganic Med Chem"},{"key":"5112_CR113","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.nbd.2016.12.021","volume":"105","author":"KR Brunden","year":"2016","unstructured":"Brunden KR, Lee VMY, Smith AB, Trojanowski JQ, Ballatore C (2016) Altered microtubule dynamics in neurodegenerative disease: therapeutic potential of microtubule-stabilizing drugs. Neurobiol Dis 105:328\u201335. https:\/\/doi.org\/10.1016\/j.nbd.2016.12.021","journal-title":"Neurobiol Dis"},{"issue":"4","key":"5112_CR114","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/1389201011314040004","volume":"14","author":"I Hozumi","year":"2013","unstructured":"Hozumi I (2013) Roles and therapeutic potential of metallothioneins in neurodegenerative diseases. Current Pharm Biotechnol 14(4):408\u201313. https:\/\/doi.org\/10.2174\/1389201011314040004","journal-title":"Current Pharm Biotechnol"},{"key":"5112_CR115","doi-asserted-by":"publisher","unstructured":"Zajkowski T, Nieznanska H, Nieznanski K (2015) Stabilization of microtubular cytoskeleton protects neurons from toxicity of N-terminal fragment of cytosolic prion protein. Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research 1853(10):2228\u201339. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.07.002","DOI":"10.1016\/j.bbamcr.2015.07.002"},{"issue":"11","key":"5112_CR116","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1523\/jneurosci.4922-11.2012","volume":"32","author":"B Zhang","year":"2012","unstructured":"Zhang B, Carroll J, Trojanowski JQ, Yao Y, Iba M, Potuzak JS et al (2012) The microtubule-stabilizing agent, Epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J Neurosci 32(11):3601\u201311. https:\/\/doi.org\/10.1523\/jneurosci.4922-11.2012","journal-title":"J Neurosci"},{"issue":"21","key":"5112_CR117","doi-asserted-by":"publisher","first-page":"8979","DOI":"10.1021\/jm301079z","volume":"55","author":"C Ballatore","year":"2012","unstructured":"Ballatore C, Brunden KR, Huryn DM, Trojanowski JQ, Lee VMY, Smith AB (2012) Microtubule stabilizing agents as potential treatment for Alzheimer\u2019s disease and related neurodegenerative tauopathies. J Med Chem 55(21):8979\u201396. https:\/\/doi.org\/10.1021\/jm301079z","journal-title":"J Med Chem"},{"issue":"28","key":"5112_CR118","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.2174\/1568026619666181129141822","volume":"18","author":"T Liang","year":"2018","unstructured":"Liang T, Fang H (2018) Structure, functions and selective inhibitors of HDAC6. Current Topics Med Chem 18(28):2429\u201347. https:\/\/doi.org\/10.2174\/1568026619666181129141822","journal-title":"Current Topics Med Chem"},{"key":"5112_CR119","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.ejmech.2017.10.040","volume":"143","author":"XX Wang","year":"2017","unstructured":"Wang XX, Wan RZ, Liu ZP (2017) Recent advances in the discovery of potent and selective HDAC6 inhibitors. European J Med Chem 143:1406\u201318. https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.040","journal-title":"European J Med Chem"},{"issue":"2","key":"5112_CR120","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/13543776.2019.1708901","volume":"30","author":"S Shen","year":"2019","unstructured":"Shen S, Kozikowski AP (2019) A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014\u20132019). Expert Opin Ther Patents 30(2):121\u201336. https:\/\/doi.org\/10.1080\/13543776.2019.1708901","journal-title":"Expert Opin Ther Patents"},{"issue":"3","key":"5112_CR121","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3727\/000000001783992650","volume":"9","author":"PA Bailleul-Winslett","year":"2001","unstructured":"Bailleul-Winslett PA, Newnam GP, Wegrzyn RD, Chernoff YO (2001) An antiprion effect of the anticytoskeletal drug latrunculin A in yeast. Gene Expression 9(3):145\u201356. https:\/\/doi.org\/10.3727\/000000001783992650","journal-title":"Gene Expression"},{"issue":"1","key":"5112_CR122","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-023-01441-4","volume":"8","author":"G Yin","year":"2023","unstructured":"Yin G, Huang J, Petela J, Jiang H, Zhang Y, Gong S et al (2023) Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS. Signal Transduct Target Ther 8(1):212","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"5112_CR123","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12031-015-0544-3","volume":"56","author":"S Zafar","year":"2015","unstructured":"Zafar S, Schmitz M, Younus N, Tahir W, Shafiq M, Llorens F et al (2015) Creutzfeldt-Jakob disease subtype-specific regional and temporal regulation of ADP ribosylation factor-1-dependent Rho\/MLC pathway at pre-clinical stage. J Mol Neurosci 56(2):329\u201348. https:\/\/doi.org\/10.1007\/s12031-015-0544-3","journal-title":"J Mol Neurosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05112-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05112-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05112-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:11:06Z","timestamp":1779797466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05112-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":124,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["5112"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05112-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,7]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}